News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BayHelix and Elsevier, Inc. Announce Four China Drug Development Awards


9/27/2012 9:55:49 AM

by Richard Daverman, PhD

September 26, 2012 -- To honor innovative drug development in China, the BayHelix Group and Elsevier Business Intelligence selected four companies and individuals for the 2012 BayHelix-Elsevier Awards, recognizing significant achievements in four different areas of pharmaceutical development. The winners were: Professor Ningshao Xia and his team at Xiamen University for the first Hepatitis E vaccine; the Hutchison MediPharma/Astra Zeneca cancer drug partnership; ZheJiang BetaPharma’s launch of its cancer drug and its innovative pricing plan; and Steve Yang of Lilly for his international leadership. More details....

Stock Symbol: (NYSE: LLY)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES